Evaluation of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiation for Non-resectable Stage III NSCLC

NCT00463515 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

77

Enrollment

OTHER

Sponsor class

Conditions

Non-Small-Cell-Lung Cancer

Interventions

DRUG: carboplatin/gemcitabine
PROCEDURE: cisplatin/radiation therapy

Sponsor

University Hospital, Antwerp

Collaborators

[object Object]
[object Object]